Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2000 2
2001 1
2002 4
2003 7
2004 3
2005 6
2006 14
2007 14
2008 15
2009 18
2010 16
2011 16
2012 30
2013 35
2014 36
2015 27
2016 19
2017 25
2018 21
2019 27
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

325 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, Deyle DR, Federspiel MJ, Fielding A, Galanis E, Lacy MQ, Leibovich BC, Liu MC, Muñoz-Alía M, Miest TC, Molina JR, Mueller S, Okuno SH, Packiriswamy N, Peikert T, Raffel C, Van Rhee F, Ungerechts G, Young PR, Zhou Y, Peng KW. Russell SJ, et al. Mayo Clin Proc. 2019 Sep;94(9):1834-1839. doi: 10.1016/j.mayocp.2019.05.006. Epub 2019 Jun 22. Mayo Clin Proc. 2019. PMID: 31235278 Free PMC article. Review.
The purpose of this article is to address a new misinformed antivaccination argument-that measles immunity is undesirable because measles virus is protective against cancer. Having worked for many years to develop engineered measles viruses as anticancer ther …
The purpose of this article is to address a new misinformed antivaccination argument-that measles immunity is undesirable because …
Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S, Bailey K, Fielding A. Aref S, et al. Viruses. 2016 Oct 22;8(10):294. doi: 10.3390/v8100294. Viruses. 2016. PMID: 27782084 Free PMC article. Review.
Oncolytic virotherapeutic agents are likely to become serious contenders in cancer treatment. The vaccine strain of measles virus is an agent with an impressive range of oncolytic activity in pre-clinical trials with increasing evidence of safety and efficacy
Oncolytic virotherapeutic agents are likely to become serious contenders in cancer treatment. The vaccine strain of measles vi
Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.
Msaouel P, Opyrchal M, Dispenzieri A, Peng KW, Federspiel MJ, Russell SJ, Galanis E. Msaouel P, et al. Curr Cancer Drug Targets. 2018;18(2):177-187. doi: 10.2174/1568009617666170222125035. Curr Cancer Drug Targets. 2018. PMID: 28228086 Free PMC article. Review.
Attenuated Edmonston lineage measles virus (MV-Edm) vaccine strains can preferentially infect and lyse a wide variety of cancer cells. ...This review describes the basic and preclinical data that facilitated the clinical translation of MV-Edm strains, and summarizes the cl …
Attenuated Edmonston lineage measles virus (MV-Edm) vaccine strains can preferentially infect and lyse a wide variety of cancer cells …
Measles Vaccine.
Griffin DE. Griffin DE. Viral Immunol. 2018 Mar;31(2):86-95. doi: 10.1089/vim.2017.0143. Epub 2017 Dec 19. Viral Immunol. 2018. PMID: 29256824 Free PMC article. Review.
Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vaccine. ...In addition, the safety record for the vaccine combined with advances in reverse genetics for negative strand viruses has expanded p
Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vacc
Measles virus: Background and oncolytic virotherapy.
Bhattacharjee S, Yadava PK. Bhattacharjee S, et al. Biochem Biophys Rep. 2018 Jan 2;13:58-62. doi: 10.1016/j.bbrep.2017.12.004. eCollection 2018 Mar. Biochem Biophys Rep. 2018. PMID: 29326986 Free PMC article. Review.
Measles is a highly transmissible disease caused by measles virus and remains a major cause of child mortality in developing countries. ...Measles virus is latently oncotropic in nature and possesses oncolytic property by syncytia formation. We try to
Measles is a highly transmissible disease caused by measles virus and remains a major cause of child mortality in developing c
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy.
Xia M, Luo D, Dong J, Zheng M, Meng G, Wu J, Wei J. Xia M, et al. J Exp Clin Cancer Res. 2019 Sep 18;38(1):408. doi: 10.1186/s13046-019-1410-x. J Exp Clin Cancer Res. 2019. PMID: 31533779 Free PMC article.
BACKGROUND: Replication-competent oncolytic viruses (OVs) have been proven to be a potent anticancer weapon for clinical therapy. ...Then, the oncolytic measles virus (MV-Edm) was coated with PEI-GOS-PEG-FA to form a viral-GOS complex (GOS/MV-Edm). The onc
BACKGROUND: Replication-competent oncolytic viruses (OVs) have been proven to be a potent anticancer weapon for clinical therapy. ... …
Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus.
May V, Berchtold S, Berger A, Venturelli S, Burkard M, Leischner C, Malek NP, Lauer UM. May V, et al. Oncol Lett. 2019 Nov;18(5):5534-5542. doi: 10.3892/ol.2019.10901. Epub 2019 Sep 20. Oncol Lett. 2019. PMID: 31612061 Free PMC article.
Measles vaccine virus (MeV) has already shown great oncolytic activity against different types of cancers, including pancreatic cancer. ...To further investigate the replication of the oncolytic MeV vectors under these distinct combinatorial conditions, viral
Measles vaccine virus (MeV) has already shown great oncolytic activity against different types of cancers, including pancreati
Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.
Veinalde R, Grossardt C, Hartmann L, Bourgeois-Daigneault MC, Bell JC, Jäger D, von Kalle C, Ungerechts G, Engeland CE. Veinalde R, et al. Oncoimmunology. 2017 Jan 31;6(4):e1285992. doi: 10.1080/2162402X.2017.1285992. eCollection 2017. Oncoimmunology. 2017. PMID: 28507792 Free PMC article.
Combination of oncolytic virotherapy with immunomodulators is emerging as a promising therapeutic strategy for numerous tumor entities. In this study, we developed measles Schwarz vaccine strain vectors encoding immunomodulators to support different phases in the es …
Combination of oncolytic virotherapy with immunomodulators is emerging as a promising therapeutic strategy for numerous tumor entitie …
Oncolytic viruses: From bench to bedside with a focus on safety.
Buijs PR, Verhagen JH, van Eijck CH, van den Hoogen BG. Buijs PR, et al. Hum Vaccin Immunother. 2015;11(7):1573-84. doi: 10.1080/21645515.2015.1037058. Hum Vaccin Immunother. 2015. PMID: 25996182 Free PMC article. Review.
Oncolytic viruses are a relatively new class of anti-cancer immunotherapy agents. Several viruses have undergone evaluation in clinical trials in the last decades, and the first agent is about to be approved to be used as a novel cancer therapy modality. In the current rev
Oncolytic viruses are a relatively new class of anti-cancer immunotherapy agents. Several viruses have undergone evaluation in clinic
Potential and clinical translation of oncolytic measles viruses.
Robinson S, Galanis E. Robinson S, et al. Expert Opin Biol Ther. 2017 Mar;17(3):353-363. doi: 10.1080/14712598.2017.1288713. Expert Opin Biol Ther. 2017. PMID: 28129716 Free PMC article. Review.
Oncolytic viruses represent a novel treatment modality that is unencumbered by the standard resistance mechanisms limiting the therapeutic efficacy of conventional antineoplastic agents. Attenuated engineered measles virus strains derived from the Edmonston vaccine
Oncolytic viruses represent a novel treatment modality that is unencumbered by the standard resistance mechanisms limiting the therap
325 results
Jump to page
Feedback